Topics

Articles

A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.

An Examination of Big Pharma Inventories

Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.

Pharma Strategies for Succeeding Amid Strong Headwinds 

Biosimilars market experiences massive growth, but regulatory and adoption challenges remain.

Getting the Lay of the Land After a Banner Year for Biosimilars

Bruce Phelan of Blue Fin discusses Novo Nordisk's purchase of Catalent manufacturing sites to increase its ability to meet the demand for the popular weight loss drug Wegovy.

Implications of Novo Nordisk Acquisition of Catalent Reverberate Through Industry

New collaboration seeks to take a significant step in the development of targeted treatments for solid tumors and an expansion of opportunities in the growing antibody-drug conjugate market.

Samsung Biologics Announces Partnership With LegoChem Biosciences to Advance Development of Antibody-Drug Conjugates 

Rusfertide could potentially be a first-in-class, transformational treatment for polycythemia vera.

Takeda Announces Partnership With Protagonist to Develop Novel Polycythemia Vera Drug

Sandoz will buy Cimerli (ranibizumab-eqrn), an interchangeable biosimilar to Lucentis (ranibizumab), for an upfront cash payment of $170 million.

Sandoz, Coherus BioSciences Reach Agreement on Sale of Lucentis Biosimilar

The US Department of Defense awarded Emergent BioSolutions Inc. with a contract worth up to $235.8 million to supply all branches of the US military with BioThrax (Anthrax Vaccine Adsorbed) for use as pre-exposure prophylaxis against anthrax disease.

Emergent BioSolutions Awarded Contract to Supply US Military With Anthrax Vaccine

Breakout session summarizes key areas that will affect all aspects of the industry. 

Trade & Channel Strategies 2023: IRA—All the Things Beyond Price Negotiations That Will Impact Your Business

Videos

Partner for Archbow Consulting discusses the conference, the IRA, and specifics of PAP business rules